Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07234903

ARC-IM Therapy To Support and Promote Recovery of Ambulatory Functions in People With Subacute and Chronic Spinal Cord Injury

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
12 (estimated)
Sponsor
Ecole Polytechnique Fédérale de Lausanne · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The EIGER study aims to evaluate the safety and preliminary efficacy of ARC-IM Therapy (Epidural Electrical Stimulation) to support and promote recovery of ambulatory functions, such as walking, in people with subacute and chronic spinal cord injury.

Conditions

Interventions

TypeNameDescription
DEVICEARC-IM TherapyAll participants will be treated with ARC-IM Therapy. The ARC-IM Lumbar System is intended to deliver electrical impulses to the lumbosacral region of the spinal cord to support ambulatory functions in people with SCI.

Timeline

Start date
2026-01-01
Primary completion
2032-01-01
Completion
2032-01-01
First posted
2025-11-19
Last updated
2025-11-19

Locations

2 sites across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT07234903. Inclusion in this directory is not an endorsement.